Automated systems maker Omnicell Inc. (NASDAQ: OMCL) is acquiring Aesynt from Francisco Partners for $275 million.
Aesynt, based in Cranberry Township, Pennsylvania, manufactures robots and automatic dispensers of medications that are designed to increase efficiency, accuracy and reduce costs for more than 1,200 health care facilities. The target has an annual Ebitda of about $20 million and $182 million in revenue. Francisco bought Aesynt in 2013, when it purchased McKesson Corp.’s automation unit. Aesynt purchased Health Robotics in 2014.
“As hospitals search for ways to provide the best patient care and also the most efficient care, customers are looking for solutions that can be scaled and customized to fit the unique needs of their health system,” says Omnicell CEO Randall Lipps. Omnicell makes automated packaging and other software products for the health care industry.
Omnicell is funding the acquisition through a combination of cash and debt. The company is receiving financing from Wells Fargo Bank NA.
Buyer interest in robot producers has been picking up. Some recent deals include Omron Corp.’s (TYO: 6645) purchase of Adept Technology Inc. and Teradyne Inc.’s (NYSE: TER) acquisition of Universal Robots.
Earlier in 2015, Francisco announced plans to buy cloud-based health care software company HealthcareSource and said it will take Procera Networks private for $240 million. Procera provides services to companies looking to improve the online experiences of customers.
Greenhill & Co., Sidley Austin LLP, Cooley LLP and Jones Day are advising Omnicell. Robert W. Baird & Co. along with Kirkland & Ellis LLP are advising Francisco Partners.